Founder of 5 different companies, among them: On-Q-ity, Inc., Dublin City University and European Personalised Medicine Association, Mara G. Aspinall is an entrepreneur and businessperson who has been at the helm of 6 different companies and presently holds the position of President, Chief Executive Officer & MD at Health Catalysts Group LLC and Managing Director at Bluestone Venture Partners LLC (which she founded in 2017).

She is also on the board of 11 other companies.

In her past career Ms. Aspinall held the position of Chairman of Predictive Biosciences, Inc., Executive Chairman of GenePeeks, Inc., Director at On-Q-ity, Inc. (she founded the company in 2011), Principal at Bain & Co., Inc., President for Genzyme Genetics, Inc., President for Genzyme Pharmaceuticals, Inc., President & CEO-Roche Tissue Diagnostics at Ventana Medical Systems, Inc., President-Genetics Division at Genzyme Corp. and Director-Client Services at Hale & Dorr LLP.

Ms. Aspinall received an undergraduate degree from Tufts University and an MBA from Harvard Business School.